J H Jansen
Overview
Explore the profile of J H Jansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van de Loosdrecht A, Cremers E, Alhan C, Duetz C, In t Hout F, Visser-Wisselaar H, et al.
Leukemia
. 2024 Jan;
38(4):840-850.
PMID: 38297135
A randomized phase-II study was performed in low/int-1 risk MDS (IPSS) to study efficacy and safety of lenalidomide without (arm A) or with (arm B) ESA/G-CSF. In arm B, patients...
2.
de Jonge P, van Hauten P, Janssen L, de Goede A, Berrien-Elliott M, van der Meer J, et al.
Cancer Immunol Immunother
. 2023 Jul;
72(10):3323-3335.
PMID: 37477653
Allogeneic natural killer (NK) cell-based immunotherapy is a promising, well-tolerated adjuvant therapeutic approach for acute myeloid leukemia (AML). For reproducible NK cell immunotherapy, a homogenous, pure and scalable NK cell...
3.
Tiso F, Koorenhof-Scheele T, Huys E, Martens J, de Graaf A, van der Reijden B, et al.
Ann Hematol
. 2022 Jan;
101(3):571-579.
PMID: 35024892
Acute myeloid leukemia (AML) is a highly heterogeneous disease showing dynamic clonal evolution patterns over time. Various subclones may be present simultaneously and subclones may show a different expansion pattern...
4.
van der Meer J, Maas R, Guldevall K, Klarenaar K, de Jonge P, Hoogstad-van Evert J, et al.
Cancer Immunol Immunother
. 2021 Sep;
70(11):3367.
PMID: 34524494
No abstract available.
5.
Van Bergen M, Marneth A, Hoogendijk A, Van Alphen F, van den Akker E, Laros-van Gorkom B, et al.
Blood
. 2021 Mar;
138(1):86-90.
PMID: 33690840
Mutations in the transcription factors GATA binding factor 1 (GATA1), growth factor independence 1B (GFI1B), and Runt-related transcription factor 1 (RUNX1) cause familial platelet and bleeding disorders. Mutant platelets exhibit...
6.
van Zeventer I, Buisman S, de Graaf A, de Haan G, Jansen J, Huls G
Ned Tijdschr Geneeskd
. 2020 Dec;
164.
PMID: 33331716
Upon ageing, hematopoietic stem or progenitor cells harboring acquired leukemia-associated mutations may expand clonally and become detectable in peripheral blood. So-called clonal hematopoiesis may be detected in 5-55% of (otherwise...
7.
van der Meer J, Maas R, Guldevall K, Klarenaar K, de Jonge P, Hoogstad-van Evert J, et al.
Cancer Immunol Immunother
. 2020 Nov;
70(5):1305-1321.
PMID: 33140189
Allogeneic natural killer (NK) cell transfer is a potential immunotherapy to eliminate and control cancer. A promising source are CD34 + hematopoietic progenitor cells (HPCs), since large numbers of cytotoxic...
8.
Hutchins K, Jansen J, Comer A, Scheer R, Zahn G, Capps A, et al.
AJNR Am J Neuroradiol
. 2020 Jun;
41(9):1707-1711.
PMID: 32586958
We report a case of bifacial weakness with paresthesia, a recognized Guillain-Barré syndrome subtype characterized by rapidly progressive facial weakness and paresthesia without ataxia or other cranial neuropathies, which was...
9.
Marneth A, Prange K, Al Hinai A, Bergevoet S, Tesi N, Janssen-Megens E, et al.
Leukemia
. 2017 Sep;
32(3):828-836.
PMID: 28871137
Overexpression of the BRE (brain and reproductive organ-expressed) gene defines a distinct pediatric and adult acute myeloid leukemia (AML) subgroup. Here we identify a promoter enriched for active chromatin marks...
10.
Wientjens G, Jansen J, Wessels H, Kibbelaar R, Beverstock G, Brederoo P, et al.
Leuk Lymphoma
. 2016 Jul;
5(5-6):415-22.
PMID: 27463354
A new EBV positive human B-cell line, BONNA-12 was established from splenic cells of a patient with a hairy cell leukemia (HCL). BONNA-12 cells grew spontaneously and formed colonies in...